Product NDC: | 0409-4778 |
Proprietary Name: | Ciprofloxacin |
Non Proprietary Name: | CIPROFLOXACIN |
Active Ingredient(s): | 400 mg/40mL & nbsp; CIPROFLOXACIN |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-4778 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077245 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060828 |
Package NDC: | 0409-4778-86 |
Package Description: | 1 VIAL in 1 CARTON (0409-4778-86) > 40 mL in 1 VIAL |
NDC Code | 0409-4778-86 |
Proprietary Name | Ciprofloxacin |
Package Description | 1 VIAL in 1 CARTON (0409-4778-86) > 40 mL in 1 VIAL |
Product NDC | 0409-4778 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CIPROFLOXACIN |
Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 20060828 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | CIPROFLOXACIN |
Strength Number | 400 |
Strength Unit | mg/40mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |